AIMS-2-TRIALS’ response to COVID-19

AIMS-2-TRIALS’ response to COVID-19

We are all very shocked and saddened by the effect that COVID-19 is having globally. We hope you are keeping safe and well during these uncertain and difficult times. We understand that some of you will be more affected than others either by being ill yourself, having...
Researcher training opportunities

Researcher training opportunities

The Early Career Researcher Autism Network was launched earlier this year at the AIMS-2-TRIALS general assembly – an event that saw over thirty researchers share ideas about their training needs. To promote training opportunities for researchers in an early...

Want to get involved?

Return to newsletter If you are interested in participating in a research study, you can sign up to our mailing list here (link to come). We will also publish details about studies that are recruiting via our participant recruitment page. Return to...
Clinical trials begin at three AIMS-2-TRIALS sites

Clinical trials begin at three AIMS-2-TRIALS sites

Development of medicines is a key priority within the AIMS-2-TRIALS research programme and this will be achieved primarily via two clinical trials. A clinical trial is a specific type of research study that evaluates an intervention; in this case a medicine. The main...